The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
NDRA · Healthcare · Shallow moat
Doesn't clear the bar
The businessTrend component abstained: Fewer than two aligned fiscal years of revenue and diluted EPS are available; the filing history does not contain a measurable trend. The other four 20% weights were renormalized over the scored 80%.
HCIL · Healthcare · Shallow moat
Doesn't clear the bar
The balanceSheet component abstained: Insufficient leverage/coverage inputs to score the balance sheet. The other four 20% weights were renormalized over the scored 80%.
| Measure | NDRA | ADMT | HCIL | VREOF |
|---|---|---|---|---|
| Moat Score (0–100) | 40 (highest) | 40 (highest) | 40 (highest) | 40 (highest) |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | — | 59 | 63 (highest) | 60 |
| Pricing power | 61 | 65 (highest) | 53 | 61 |
| Returns on capital | 0 | 4 (highest) | 0 | 0 |
| Balance-sheet safety | 55 (highest) | 28 | — | 55 (highest) |
| Capital allocation | 44 (highest) | 44 (highest) | 44 (highest) | 24 |
| No price data | No price data | No price data | No price data | |
| Market cap | $5.7M | $2.7M | Not reported | $7.2B |
| Moat tier | Shallow moat | Shallow moat | Shallow moat | Shallow moat |
| Filing date | FY2025 | FY2026 | FY2025 | FY2025 |